How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing

When your products are authorized across dozens of markets, your pharmacovigilance obligations multiply fast. Reporting timelines, documentation formats, local language requirements, and risk management plans can differ significantly from one country to the next, and even centralized EMA approval still requires compliance with safety regulations across all 30 EU and EEA member states. For internal safety teams already stretched thin, keeping pace with this complexity while supporting market expansion and M&A activity is a genuine operational challenge.
Outsourcing local affiliate pharmacovigilance can resolve that pressure, but only when it is structured correctly. The wrong approach creates new risks: under-resourced affiliates, siloed activities, misalignment between local and global operations, and non-compliance issues that ultimately fall on the Marketing Authorization Holder.
This guide gives you a practical framework for getting it right. You will learn how to evaluate your current capabilities against a four-pillar best practice model covering People, Processes, Platforms, and Program Management. You will also find six concrete best practices for structuring outsourced local affiliate PV, a breakdown of the most common pitfalls organizations encounter, and a real-world case study showing how a mid-sized biopharmaceutical company achieved standardized oversight across 94 countries after consolidating to a single affiliate PV provider.
The frameworks here will help you maintain inspection readiness, protect your regulatory timelines, and build a local PV model that holds up under scrutiny. Download now to build a stronger foundation for compliant, scalable local affiliate pharmacovigilance.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.